| Dr Redi Ferizaj, MD | |
|
2222 Benwood St, Harlingen, TX 78550-8532 | |
| (956) 389-2448 | |
| (956) 389-2498 |
| Full Name | Dr Redi Ferizaj |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 23 Years |
| Location | 2222 Benwood St, Harlingen, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568950350 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 67146 (Connecticut) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hartford Hospital | Hartford, CT | Hospital |
| Manchester Memorial Hospital | Manchester, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hartford Healthcare Medical Group Specialists Pllc | 3173866241 | 1138 |
| Hospitalist Medicine Physicians Of Connecticut Llc | 8628104072 | 32 |
News Archive
A Department of Veterans Affairs and Northwestern University researcher has developed the first reliable measure of neurobehavioral functioning that will help physicians predict the likelihood of a patient recovering consciousness during coma from severe brain injury within the first year of injury-with up to 86 percent certainty.
As Congress debates cutting prescription drug costs, a poll released Tuesday found the vast majority of adults — regardless of their political party or age — support letting the federal government negotiate drug prices for Medicare beneficiaries and those in private health insurance plans.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that it has successfully treated Duchenne muscular dystrophy (DMD) in an animal model with its proprietary gene therapy. The proof of concept studies were performed in collaboration with the group of Professor Irene Bozzoni (University of Rome, La Sapienza, Italy) and demonstrated effectiveness in the heart as well as in skeletal muscles.
A new study of the U.K. and South Africa variants of SARS-CoV-2 predicts that current vaccines and certain monoclonal antibodies may be less effective at neutralizing these variants and that the new variants raise the specter that reinfections could be more likely.
With five years and $25M invested in R&D, in partnership with industry leading manufacturers (Sirona, Meisinger, SycoTec - R&D spin off of KaVo), ProDrive Systems today announced the launch of ProDrive products nationwide in Canada with an exclusive multimillion-dollar agreement through Patterson Dental Canada.
› Verified 4 days ago
| Entity Name | Hospitalist Medicine Physicians Of Connecticut Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558696153 PECOS PAC ID: 8628104072 Enrollment ID: O20100325000168 |
News Archive
A Department of Veterans Affairs and Northwestern University researcher has developed the first reliable measure of neurobehavioral functioning that will help physicians predict the likelihood of a patient recovering consciousness during coma from severe brain injury within the first year of injury-with up to 86 percent certainty.
As Congress debates cutting prescription drug costs, a poll released Tuesday found the vast majority of adults — regardless of their political party or age — support letting the federal government negotiate drug prices for Medicare beneficiaries and those in private health insurance plans.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that it has successfully treated Duchenne muscular dystrophy (DMD) in an animal model with its proprietary gene therapy. The proof of concept studies were performed in collaboration with the group of Professor Irene Bozzoni (University of Rome, La Sapienza, Italy) and demonstrated effectiveness in the heart as well as in skeletal muscles.
A new study of the U.K. and South Africa variants of SARS-CoV-2 predicts that current vaccines and certain monoclonal antibodies may be less effective at neutralizing these variants and that the new variants raise the specter that reinfections could be more likely.
With five years and $25M invested in R&D, in partnership with industry leading manufacturers (Sirona, Meisinger, SycoTec - R&D spin off of KaVo), ProDrive Systems today announced the launch of ProDrive products nationwide in Canada with an exclusive multimillion-dollar agreement through Patterson Dental Canada.
› Verified 4 days ago
| Entity Name | Hartford Healthcare Medical Group Specialists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023584216 PECOS PAC ID: 3173866241 Enrollment ID: O20190514001441 |
News Archive
A Department of Veterans Affairs and Northwestern University researcher has developed the first reliable measure of neurobehavioral functioning that will help physicians predict the likelihood of a patient recovering consciousness during coma from severe brain injury within the first year of injury-with up to 86 percent certainty.
As Congress debates cutting prescription drug costs, a poll released Tuesday found the vast majority of adults — regardless of their political party or age — support letting the federal government negotiate drug prices for Medicare beneficiaries and those in private health insurance plans.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that it has successfully treated Duchenne muscular dystrophy (DMD) in an animal model with its proprietary gene therapy. The proof of concept studies were performed in collaboration with the group of Professor Irene Bozzoni (University of Rome, La Sapienza, Italy) and demonstrated effectiveness in the heart as well as in skeletal muscles.
A new study of the U.K. and South Africa variants of SARS-CoV-2 predicts that current vaccines and certain monoclonal antibodies may be less effective at neutralizing these variants and that the new variants raise the specter that reinfections could be more likely.
With five years and $25M invested in R&D, in partnership with industry leading manufacturers (Sirona, Meisinger, SycoTec - R&D spin off of KaVo), ProDrive Systems today announced the launch of ProDrive products nationwide in Canada with an exclusive multimillion-dollar agreement through Patterson Dental Canada.
› Verified 4 days ago
| Entity Name | Sound Physicians Of Massachusetts Ii Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306376397 PECOS PAC ID: 9436421567 Enrollment ID: O20220607002184 |
News Archive
A Department of Veterans Affairs and Northwestern University researcher has developed the first reliable measure of neurobehavioral functioning that will help physicians predict the likelihood of a patient recovering consciousness during coma from severe brain injury within the first year of injury-with up to 86 percent certainty.
As Congress debates cutting prescription drug costs, a poll released Tuesday found the vast majority of adults — regardless of their political party or age — support letting the federal government negotiate drug prices for Medicare beneficiaries and those in private health insurance plans.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that it has successfully treated Duchenne muscular dystrophy (DMD) in an animal model with its proprietary gene therapy. The proof of concept studies were performed in collaboration with the group of Professor Irene Bozzoni (University of Rome, La Sapienza, Italy) and demonstrated effectiveness in the heart as well as in skeletal muscles.
A new study of the U.K. and South Africa variants of SARS-CoV-2 predicts that current vaccines and certain monoclonal antibodies may be less effective at neutralizing these variants and that the new variants raise the specter that reinfections could be more likely.
With five years and $25M invested in R&D, in partnership with industry leading manufacturers (Sirona, Meisinger, SycoTec - R&D spin off of KaVo), ProDrive Systems today announced the launch of ProDrive products nationwide in Canada with an exclusive multimillion-dollar agreement through Patterson Dental Canada.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Redi Ferizaj, MD 2222 Benwood St, Harlingen, TX 78550-8532 Ph: (956) 389-2448 | Dr Redi Ferizaj, MD 2222 Benwood St, Harlingen, TX 78550-8532 Ph: (956) 389-2448 |
News Archive
A Department of Veterans Affairs and Northwestern University researcher has developed the first reliable measure of neurobehavioral functioning that will help physicians predict the likelihood of a patient recovering consciousness during coma from severe brain injury within the first year of injury-with up to 86 percent certainty.
As Congress debates cutting prescription drug costs, a poll released Tuesday found the vast majority of adults — regardless of their political party or age — support letting the federal government negotiate drug prices for Medicare beneficiaries and those in private health insurance plans.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that it has successfully treated Duchenne muscular dystrophy (DMD) in an animal model with its proprietary gene therapy. The proof of concept studies were performed in collaboration with the group of Professor Irene Bozzoni (University of Rome, La Sapienza, Italy) and demonstrated effectiveness in the heart as well as in skeletal muscles.
A new study of the U.K. and South Africa variants of SARS-CoV-2 predicts that current vaccines and certain monoclonal antibodies may be less effective at neutralizing these variants and that the new variants raise the specter that reinfections could be more likely.
With five years and $25M invested in R&D, in partnership with industry leading manufacturers (Sirona, Meisinger, SycoTec - R&D spin off of KaVo), ProDrive Systems today announced the launch of ProDrive products nationwide in Canada with an exclusive multimillion-dollar agreement through Patterson Dental Canada.
› Verified 4 days ago
Jesus Rodriguez, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2222 Benwood St, Harlingen, TX 78550 Phone: 956-389-2448 | |
Bright Ohene Odei, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 707 W Sesame Dr, Harlingen, TX 78550 Phone: 956-423-8042 Fax: 469-893-7810 | |
Erica Ruiz Espinoza, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 707 W Sesame Dr, Harlingen, TX 78550 Phone: 956-423-8042 Fax: 956-423-2907 | |
Mr. Prasad V Movva, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 922 E Tyler Ave, Harlingen, TX 78550 Phone: 956-440-7000 Fax: 956-440-7042 | |
Dr. Jason E Peters, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2106 Hale Avenue, Harlingen, TX 78550 Phone: 956-423-9111 Fax: 956-423-9273 | |
Dr. John Barry Ranelle, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1214 E Bowie Ave, Harlingen, TX 78550 Phone: 956-536-7794 Fax: 956-686-2708 | |
Edward G. Oorjitham, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1205 N Ed Carey Dr, Suite 2c, Harlingen, TX 78550 Phone: 956-440-8020 Fax: 956-440-8131 |